Hilary McNutt

Hilary McNutt, CPA, currently serves as Associate Director of External Reporting and Equity Compensation at Marinus Pharma, having started in February 2022. Prior to this role, McNutt held positions as Senior Manager of Financial Compliance and Reporting at Marinus Pharma, Director of Corporate Financial Reporting at Inotiv, and Manager of Corporate Financial Reporting at both Novartis and Endocyte, where Endocyte was acquired by Novartis in December 2018. McNutt's earlier experience includes roles as Senior Financial Analyst II and Senior Financial Analyst I at Crowe Horwath LLP, as well as Accounts Receivable Analyst at Simon Property Group. McNutt holds a B.S. in Chemistry from Butler University and a Master of Science in Accounting from Indiana University - Kelley School of Business.